Because of its central role in disease, scientists are intensely focused on VCAM-1 as both a and a drug target .
: VCAM-1 acts as a receptor for the integrin VLA-4 ( vcam 1
Discovered in the late 1980s, VCAM 1 has since been implicated in everything from the body’s natural defense against pathogens to the chronic inflammation that drives heart disease and autoimmune disorders. In recent years, its role has expanded into the fields of oncology and COVID-19 pathology, making it a high-value target for next-generation therapeutics. Because of its central role in disease, scientists
While acute VCAM 1 expression is protective, chronic upregulation drives pathology. vcam 1
This mechanism turns Vcam 1 from a protector into a contributor to pathology.